Drug
safety advice |
|
Tamoxifen
for breast cancer: drug interactions involving CYP2D6, genetic variants,
and variability in clinical response |
|
Memantine
pump device (Ebixa): risk of medication errors
|
Hot
topics |
|
Tiotropium:
safety studies of Spiriva Respimat
|
|
Oral
bisphosphonates: oesophageal cancer riskinsufficient evidence
of a link |
Other
information from the MHRA |
|
Patient
Information Leaflet of the month: Spiriva and Spiriva Respimat |